富尔维酸保护肝组织免受阿莫西林/克拉夫兰酸诱导的肝毒性
Hasan Mansur Durgun1, Eda Yildizhan2
1Department of Emergency, Dicle University, Faculty of Medicine Hospital, 21280 Sur/Diyarbakır, Turkey.
富尔维酸通过减少氧化应激和亡来保护肝脏免受阿莫西西林 - 克拉夫兰酸的损伤. 这种天然化合物在预防药物诱导的肝损伤方面表现有前途.
科学领域:
- 自然化合物的肝脏保护作用.
- 药物诱导的肝损伤机制.
- 在毒理学中氧化应激和亡.
背景情况:
- 氨基氨酸与药物诱导的肝损伤有关.
- 富尔维酸具有抗氧化和抗质的特性.
研究的目的:
- 评估富尔维酸对阿莫西西林 - 克拉夫兰酸诱导的肝毒性的保护作用.
- 阐明底层的抗氧化和抗瘤机制.
主要方法:
- 一个大鼠模型的阿莫西西林 - 克拉夫兰酸诱导的肝毒性.
- 对肝损伤和氧化应激标志物的生物化学测试.
- 组织病理学和免疫组织化学分析以检测组织损伤和亡.
- 肝脏排毒能力的功能测试.
- 在分析用于分子目标预测.
主要成果:
- 氨基氨酸显著增加了肝损伤标志物,氧化应激和亡.
- 富尔维酸联合治疗改善了肝酶水平和组织学损伤.
- 富尔维克酸调节的亡标志物 (BAX和BCL2) 和改善的解毒.
- 在基分析表明,富尔维克酸的标参与了代谢和扩散途径.
结论:
- 富尔维克酸显示出显著的肝保护作用,防止阿莫西西林-克拉夫兰酸诱导的肝损伤.
- 保护机制涉及抗氧化和抗菌活性.
- 需要进一步的研究来探索剂量反应和临床适用性.
更多相关视频
06:12Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Hepatic Drug Excretion: Influencing Factors
